CD177 and cancer: CD177 overexpression was significantly correlated with a favorable prognosis for gastric cancer (20) and CD177+ neutrophils suppress epithelial cell tumorigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer (21), pointing to a protective role of CD177 in cancer.